Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Robb

Showing results (51-60 of 74) with videos related to

Pageof 8
Sort By:
Journal of Wildlife Diseases|April 1, 1996
Exposure of wild waterfowl to Mycoplasma anatisM D Samuel, D R Goldberg, C B Thomas, et al.
AIDS (London, England)|June 16, 2001
First CRF01_AE/B recombinant of HIV-1 is found in ThailandS Tovanabutra, V Polonis, M De Souza, et al.
Journal of Medicinal Chemistry|July 31, 2019
Free Ligand 1D NMR Conformational Signatures To Enhance Structure Based Drug Design of a Mcl-1 Inhibitor (AZD5991) and Other Synthetic MacrocyclesAmber Y S Balazs, Rodrigo J Carbajo, Nichola L Davies, et al.
Journal of Medicinal Chemistry|March 1, 2021
Correction to "Free Ligand 1D NMR Conformational Signatures To Enhance Structure Based Drug Design of a Mcl-1 Inhibitor (AZD5991) and Other Synthetic Macrocycles"Amber Y S Balazs, Rodrigo J Carbajo, Nichola L Davies, et al.
Journal of Medicinal Chemistry|January 16, 2014
Optimization of brain penetrant 11β-hydroxysteroid dehydrogenase type I inhibitors and in vivo testing in diet-induced obese miceFrederick W Goldberg, Alexander G Dossetter, James S Scott, et al.
Bioorganic & Medicinal Chemistry|February 6, 2018
Optimization of permeability in a series of pyrrolotriazine inhibitors of IRAK4Sébastien L Degorce, Rana Anjum, Keith S Dillman, et al.
Journal of Medicinal Chemistry|October 18, 2019
Discovery of a Series of 5-Azaquinazolines as Orally Efficacious IRAK4 Inhibitors Targeting MyD88<sup>L265P</sup> Mutant Diffuse Large B Cell LymphomaSébastien L Degorce, Rana Anjum, Andrew Bloecher, et al.
Chemical Communications (Cambridge, England)|December 25, 2013
Potent, selective small molecule inhibitors of type III phosphatidylinositol-4-kinase α- but not β-inhibit the phosphatidylinositol signaling cascade and cancer cell proliferationMichael J Waring, David M Andrews, Paul F Faulder, et al.
Bioorganic & Medicinal Chemistry|April 19, 2022
Identification and optimisation of a pyrimidopyridone series of IRAK4 inhibitorsIain A Cumming, Sébastien L Degorce, Anna Aagaard, et al.
Journal of Medicinal Chemistry|June 27, 2014
Identification, optimization, and pharmacology of acylurea GHS-R1a inverse agonistsWilliam McCoull, Peter Barton, Alastair J H Brown, et al.
Pageof 8

Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
Journal of Wildlife Diseases|April 1, 1996
Exposure of wild waterfowl to Mycoplasma anatisM D Samuel, D R Goldberg, C B Thomas, et al.
AIDS (London, England)|June 16, 2001
First CRF01_AE/B recombinant of HIV-1 is found in ThailandS Tovanabutra, V Polonis, M De Souza, et al.
Journal of Medicinal Chemistry|July 31, 2019
Free Ligand 1D NMR Conformational Signatures To Enhance Structure Based Drug Design of a Mcl-1 Inhibitor (AZD5991) and Other Synthetic MacrocyclesAmber Y S Balazs, Rodrigo J Carbajo, Nichola L Davies, et al.
Journal of Medicinal Chemistry|March 1, 2021
Correction to "Free Ligand 1D NMR Conformational Signatures To Enhance Structure Based Drug Design of a Mcl-1 Inhibitor (AZD5991) and Other Synthetic Macrocycles"Amber Y S Balazs, Rodrigo J Carbajo, Nichola L Davies, et al.
Journal of Medicinal Chemistry|January 16, 2014
Optimization of brain penetrant 11β-hydroxysteroid dehydrogenase type I inhibitors and in vivo testing in diet-induced obese miceFrederick W Goldberg, Alexander G Dossetter, James S Scott, et al.
Bioorganic & Medicinal Chemistry|February 6, 2018
Optimization of permeability in a series of pyrrolotriazine inhibitors of IRAK4Sébastien L Degorce, Rana Anjum, Keith S Dillman, et al.
Journal of Medicinal Chemistry|October 18, 2019
Discovery of a Series of 5-Azaquinazolines as Orally Efficacious IRAK4 Inhibitors Targeting MyD88<sup>L265P</sup> Mutant Diffuse Large B Cell LymphomaSébastien L Degorce, Rana Anjum, Andrew Bloecher, et al.
Chemical Communications (Cambridge, England)|December 25, 2013
Potent, selective small molecule inhibitors of type III phosphatidylinositol-4-kinase α- but not β-inhibit the phosphatidylinositol signaling cascade and cancer cell proliferationMichael J Waring, David M Andrews, Paul F Faulder, et al.
Bioorganic & Medicinal Chemistry|April 19, 2022
Identification and optimisation of a pyrimidopyridone series of IRAK4 inhibitorsIain A Cumming, Sébastien L Degorce, Anna Aagaard, et al.
Journal of Medicinal Chemistry|June 27, 2014
Identification, optimization, and pharmacology of acylurea GHS-R1a inverse agonistsWilliam McCoull, Peter Barton, Alastair J H Brown, et al.
Pageof 8